Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 5, 2004, Pages 1369-1374

  Blanco, Paola G ^a   Freedman, Steven D ^a,d   Lopez, Mari C ^c   Ollero, Mario ^a   Comen, Elizabeth ^a   Laposata, Michael ^b   Alvarez, Juan G ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL SAN RAFAEL   (Spain)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Docosahexaenoic acid; Respiratory distress syndrome; Surfactant

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; DOCOSAHEXAENOIC ACID; LUNG SURFACTANT;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PREGNANCY; PREMATURITY; PRIORITY JOURNAL;

EID: 2542458252     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.11.001     Document Type: Article

References (17)

1. Gluck L, Kulovich MV, Borer RC Jr, Brenner PH, Anderson GG, Spellacy WN. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 1971;109:440-5.
2. Alvarez JG, Richardson DK, Ludmir J. Prediction of respiratory distress syndrome by the novel dipalmitoyl phosphatidylcholine test. Obstet Gynecol 1996;87:429-33.
3. Caughey AB, Parer JT. Recommendations for repeat courses of antenatal corticosteroids: a decision analysis. Am J Obstet Gynecol 2002;186:1221-9.
4. Effect of corticosteroids for fetal maturation on perinatal outcomes: NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8.
5. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995;173:322-35.
6. Leung TN, Lam PM, Ng PC, Lau TK. Repeated courses of antenatal corticosteroids: Is it justified? Acta Obstet Gynecol Scand 2003;82:589-96.
7. Cooke R. The current use of exogenous surfactants in the newborn. BJOG 1995;102:679-81.
8. Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis 1975;111:657-88.
9. Akira S, Mason R, Smith D, Firestone J, Browning M, Voelker D. Pulmonary surfactant secretion is regulated by the physical state of extracellular phosphatidylcholine. J Biol Chem 1992;267:19884-90.
10. Mallampalli RK, Salome RG, Spector AA. Regulation of CTP: choline phosphate cytidylytransferase by polyunsaturated n-3 fatty acids. Am J Physiol 1994;267:L641-8.
11. Baybutt RC, Smith JE, Yey YY. The effects of dietary fish oil on alveolar type II cell fatty acids and lung surfactant phospholipids. Lipids 1993;28:167-72.
12. Alvarez JG, Slomovic B, Ludmir J. Analysis of dipalmitoyl phosphatidylcholine in amniotic fluid by enzymatic hydrolysis and high-performance thin-layer chromatography (HPTLC): reflectance spectrodensitometry. J Chromatogr 1995;665:79-87.
13. Freedman SD, Blanco PG, Shea JC, Alvarez JG. Analysis of lipid abnormalities in CF mice. Methods Mol Med 2002;70:517-24.
14. Bayer H, Bonnar J, Phizackerley PJ, Moore RA, Wylie F. Amniotic fluid phospholipids in normal and abnormal pregnancy. J Obstet Gynaecol Br Commonw 1973;80:333-7.
15. Arterburn LM, Boswell KD, Henwood SM, Kyle DJ. A developmental safety study in rats using DHA- and ARA-rich single-cell oils. Food Chem Toxicol 2000;38:763-71.
16. Hammond BG, Mayhew DA, Holson JF, Nemec MD, Mast RW, Sander WJ. Safety assessment of DHA-rich microalgae from Schizochytrium sp. Regul Toxicol Pharmacol 2001;33:205-17.
17. Martinez M, Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem 1998;71:2528-33.